201 related articles for article (PubMed ID: 15769928)
21. Cefuroxime-induced cutaneous pustular leukocytoclastic vasculitis with Koebner phenomenon on the donor area of a skin graft.
Montero I; Gutiérrez-González E; Álvarez-Pérez A; Sánchez-Aguilar D; Ginarte M; Toribio J
Int J Dermatol; 2015 Nov; 54(11):1338-9. PubMed ID: 26275574
[No Abstract] [Full Text] [Related]
22. Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report.
Guillemois S; Patsouris A; Peyraga G; Chassain K; Le Corre Y; Campone M; Augereau P
Clin Breast Cancer; 2018 Oct; 18(5):e755-e758. PubMed ID: 30120047
[No Abstract] [Full Text] [Related]
23. Leukocytoclastic vasculitis associated with sotalol therapy.
Rustmann WC; Carpenter MT; Harmon C; Botti CF
J Am Acad Dermatol; 1998 Jan; 38(1):111-2. PubMed ID: 9448217
[No Abstract] [Full Text] [Related]
24. Methotrexate related cutaneous vasculitis.
Torner O; Ruber C; Olive A; Tena X
Clin Rheumatol; 1997 Jan; 16(1):108-9. PubMed ID: 9132315
[No Abstract] [Full Text] [Related]
25. Erythema multiforme after radiotherapy with aromatase inhibitor administration in breast-conservation treatment for breast cancer.
Nakatani K; Matsumoto M; Ue H; Nishioka A; Tanaka Y; Kodama H; Sasaguri S; Ogawa Y
Breast Cancer; 2008; 15(4):321-3. PubMed ID: 18278432
[TBL] [Abstract][Full Text] [Related]
26. Rituximab-induced leukocytoclastic vasculitis: a case report.
Kandula P; Kouides PA
Arch Dermatol; 2006 Feb; 142(2):246-7. PubMed ID: 16490860
[No Abstract] [Full Text] [Related]
27. Antineutrophil cytoplasmic antibody-positive cutaneous leukocytoclastic vasculitis associated with propylthiouracil therapy.
Sheen YS; Chu CY; Yu HS
Arch Dermatol; 2006 Jul; 142(7):879-80. PubMed ID: 16847204
[No Abstract] [Full Text] [Related]
28. Leukocytoclastic vasculitis due to duloxetine.
Erfan G; Alp R; Albayrak S; Oguz K; Kalayci S; Oznur M; Kulac M
Eur J Dermatol; 2015 Apr; 25(2):194-5. PubMed ID: 25547420
[No Abstract] [Full Text] [Related]
29. Atypical cutaneous vasculitis under lapatinib.
Peuvrel L; Quereux G; Brocard A; Saint-Jean M; Freour E; Josselin N; Audouin AF; El Kouri C; Dreno B
Eur J Dermatol; 2013; 23(4):540-1. PubMed ID: 23965414
[No Abstract] [Full Text] [Related]
30. [On the article by M. Delbarre].
Le Coz C
Ann Dermatol Venereol; 1998 Sep; 125(9):609. PubMed ID: 9805554
[No Abstract] [Full Text] [Related]
31. Atenolol-induced cutaneous vasculitis.
Wolf R; Ophir J; Elman M; Krakowski A
Cutis; 1989 Mar; 43(3):231-3. PubMed ID: 2523289
[TBL] [Abstract][Full Text] [Related]
32. Teicoplanin-induced purpuric eruption with leukocytoclastic vasculitis.
Uchida Y; Higashi Y; Kanekura T
Eur J Dermatol; 2014; 24(6):689-90. PubMed ID: 25179378
[No Abstract] [Full Text] [Related]
33. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature.
Jhaveri K; Halperin P; Shin SJ; Vahdat L
Breast Cancer Res Treat; 2007 Dec; 106(3):315-8. PubMed ID: 17972174
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
Wheler J; Johnson M; Seidman A
Semin Oncol; 2006 Dec; 33(6):672-80. PubMed ID: 17145347
[TBL] [Abstract][Full Text] [Related]
35. A case of hypersensitivity vasculitis after vinorelbine injection in a patient with metastatic breast cancer.
Bilku DK; Brammer CV
Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):363-4. PubMed ID: 17419038
[No Abstract] [Full Text] [Related]
36. Cutaneous vasculitis from maprotiline.
Oakley AM; Hodge L
Aust N Z J Med; 1985 Apr; 15(2):256-7. PubMed ID: 3161496
[TBL] [Abstract][Full Text] [Related]
37. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature.
Lycette JL; Luoh SW; Beer TM; Deloughery TG
Breast Cancer Res Treat; 2006 Oct; 99(3):249-55. PubMed ID: 16752073
[TBL] [Abstract][Full Text] [Related]
38. Adalimumab causing vasculitis.
Orpin SD; Majmudar VB; Soon C; Azam NA; Salim A
Br J Dermatol; 2006 May; 154(5):998-9. PubMed ID: 16634911
[No Abstract] [Full Text] [Related]
39. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
Monnier AM
Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
[TBL] [Abstract][Full Text] [Related]
40. Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.
Holmes CE; Huang JC; Pace TR; Howard AB; Muss HB
Clin Cancer Res; 2008 May; 14(10):3070-6. PubMed ID: 18483373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
